1. Home
  2. CLDX vs DCO Comparison

CLDX vs DCO Comparison

Compare CLDX & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$31.29

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$122.57

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
DCO
Founded
N/A
1849
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
CLDX
DCO
Price
$31.29
$122.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$44.50
$150.20
AVG Volume (30 Days)
882.3K
150.3K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,743,000.00
$824,730,000.00
Revenue This Year
$111.39
$7.38
Revenue Next Year
$235.85
$8.58
P/E Ratio
N/A
N/A
Revenue Growth
87.78
4.85
52 Week Low
$14.40
$51.76
52 Week High
$31.85
$140.02

Technical Indicators

Market Signals
Indicator
CLDX
DCO
Relative Strength Index (RSI) 61.73 46.20
Support Level $24.70 $87.68
Resistance Level N/A $128.17
Average True Range (ATR) 1.39 5.40
MACD -0.06 -1.37
Stochastic Oscillator 81.42 6.55

Price Performance

Historical Comparison
CLDX
DCO

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: